ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,159.10
-0.92%
S&P ASX All Technology
3,805.40
-1.15%
Brent Oil
74.555
0.61%
US Dollar vs AUD
1.60889
0.05%
Bitcoin
92,491.01
-0.19%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Oxford Biomedica Plc (OXB) Share Price

Oxford Biomedica Plc

Oxford Biomedica Plc (OXB)

LSE
419.00
-2.50
(-0.59%)
Closed 31 December 3:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
419.00
Bid
420.50
Offer
422.00
Volume
66,851
417.50 Day's Range 425.00
167.00 52 Week Range 450.00
Market Cap
441.458M
Previous Close
421.50
Open
421.50
Last Trade
6488
@
419.51291
(O)
Last Trade Time
Financial Volume
280,887p
VWAP
420.1684
Average Volume (3m)
172,274
Shares Outstanding
105,359,856
Dividend Yield
-
PE Ratio
-2.41
Earnings Per Share (EPS)
-1.75
Revenue
89.54M
Net Profit
-184.16M

About Oxford Biomedica Plc

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
www.oxb.com
Headquarters
Oxford, Gbr
Founded
-
Oxford Biomedica Plc is listed in the Medicinal Chems,botanicl Pds sector of the London Stock Exchange with ticker OXB. The last closing price for Oxford Biomedica was 421.50p. Over the last year, Oxford Biomedica shares have traded in a share price range of 167.00p to 450.00p.

Oxford Biomedica currently has 105,359,856 shares in issue. The market capitalisation of Oxford Biomedica is £444.09 million. Oxford Biomedica has a price to earnings ratio (PE ratio) of -2.41.

Ask ADVFN Intelligence (AI)

OXB Latest News

More News

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC 02 December 2024     OXB Total Voting Rights   Oxford, UK - 02 December 2024: Oxford Biomedica Plc ( "OXB" or the "Company"; LSE: OXB), a quality and innovation-led cell...

02 December 2024
RNS Regulatory News

Oxford Biomedica PLC Grant of options

Oxford Biomedica PLC 22 November 2024     Grant of options   Oxford, UK - 22 November 2024: Oxford Biomedica plc ("OXB" or the "Company"; LSE: OXB), a quality and innovation-led cell and gene...

23 November 2024
RNS Regulatory News

OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical development

OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical development Oxford, UK – 20 November 2024: OXB (LSE: OXB), a quality and...

20 November 2024
GlobeNewswire Inc.

Oxford Biomedica PLC Board Changes

Oxford Biomedica PLC 18 November 2024     Board Changes -     Appointment of Colin Bond, a highly experienced Board member and Audit Committee Chair with extensive international CDMO and...

18 November 2024
RNS Regulatory News

Oxford Biomedica PLC OXB to present at Jefferies Healthcare Conference

Oxford Biomedica PLC 15 November 2024         OXB to present at the Jefferies London Healthcare Conference Oxford, UK - 15 November 2024: OXB (LSE: OXB), a quality and innovation-led cell and...

15 November 2024
RNS Non-Regulatory

Oxford Biomedica PLC Grant of options

Oxford Biomedica PLC 05 November 2024     Grant of options   Oxford, UK - 05 November 2024: Oxford Biomedica plc ("OXB" or the "Company"; LSE: OXB), a quality and innovation-led cell and gene...

06 November 2024
RNS Regulatory News

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC 04 November 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name OXFORD BIOMEDICA PLC UK or Non-UK Issuer UK 2...

04 November 2024
RNS Regulatory News

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC 01 November 2024       OXB Total Voting Rights   Oxford, UK - 01 November 2024: Oxford Biomedica Plc ( "OXB" or the "Company"; LSE: OXB), a quality and innovation-led cell...

01 November 2024
RNS Regulatory News

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC 31 October 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name OXFORD BIOMEDICA PLC UK or Non-UK Issuer UK 2...

31 October 2024
RNS Regulatory News

Oxford Biomedica PLC Block Listing Application

Oxford Biomedica PLC 21 October 2024     OXB Block Listing Application Oxford, UK - 21 October 2024: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces...

21 October 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-4-0.945626477541423430412.565046424.21842379DE
4-11-2.55813953488430438406.5146498426.14920718DE
123910.2631578947380450360172274412.00123493DE
26112.536.704730832306.5450296160287382.49423149DE
52204.595.337995338214.5450167211157289.05493116DE
156-777-64.966555183911961294164.4187340368.82881385DE
260-246-36.9924812036651678164.4180911606.80818118DE

OXB - Frequently Asked Questions (FAQ)

What is the current Oxford Biomedica share price?
The current share price of Oxford Biomedica is 419.00p
How many Oxford Biomedica shares are in issue?
Oxford Biomedica has 105,359,856 shares in issue
What is the market cap of Oxford Biomedica?
The market capitalisation of Oxford Biomedica is GBP 444.09M
What is the 1 year trading range for Oxford Biomedica share price?
Oxford Biomedica has traded in the range of 167.00p to 450.00p during the past year
What is the PE ratio of Oxford Biomedica?
The price to earnings ratio of Oxford Biomedica is -2.41
What is the cash to sales ratio of Oxford Biomedica?
The cash to sales ratio of Oxford Biomedica is 4.95
What is the reporting currency for Oxford Biomedica?
Oxford Biomedica reports financial results in GBP
What is the latest annual turnover for Oxford Biomedica?
The latest annual turnover of Oxford Biomedica is GBP 89.54M
What is the latest annual profit for Oxford Biomedica?
The latest annual profit of Oxford Biomedica is GBP -184.16M
What is the registered address of Oxford Biomedica?
The registered address for Oxford Biomedica is WINDRUSH COURT, TRANSPORT WAY, OXFORD, OX4 6LT
What is the Oxford Biomedica website address?
The website address for Oxford Biomedica is www.oxb.com
Which industry sector does Oxford Biomedica operate in?
Oxford Biomedica operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CLAICel Ai Plc
0.085p
(41.67%)
20.65M
ZEDZenova Group Plc
0.675p
(22.73%)
4.33M
GFINGfinity Plc
0.07p
(21.74%)
118M
SDXSdx Energy Plc
0.424p
(21.14%)
28.44M
OBDOxford Biodynamics Plc
1.45p
(20.83%)
1.79M
QUIZQuiz Plc
0.745p
(-15.82%)
5.25M
SRESSunrise Resources Plc
0.0275p
(-15.38%)
43.75M
PPSProton Motor Power Systems Plc
0.275p
(-15.38%)
401.8k
ALTEAlteration Earth Plc
10.75p
(-14.00%)
1.87M
SYMESupply@me Capital Plc
0.0034p
(-13.92%)
513.5M
TRPTower Resources Plc
0.037p
(8.82%)
991.59M
SYMESupply@me Capital Plc
0.0034p
(-13.92%)
513.5M
NTVONativo Resources Plc
0.002p
(0.00%)
399.34M
PREMPremier African Minerals Limited
0.044p
(-12.87%)
296.47M
NTOGNostra Terra Oil And Gas Company Plc
0.027p
(3.85%)
273.27M

Discussion

View Full Feed
zerosnoop zerosnoop 5 seconds ago
Oh so the debt to Temple University is going to get written off. Just what the paid bashers & naked shorters didn't want to hear before the xmas break hah hah. All the ducks are being lined up now. The SHORT SQUEEZE will be fun to watch. The PROVEN AOT is a "GAME CHANGER" for the oil industry.
QSEP
gitreal gitreal 16 seconds ago
It is 17 miles from the "plant" to the pile of rocks on the hill top. I am sorry that you and Condor do not know how to use Google Earth, but maybe you could have a grandkid help you with that. It even says that distance in one of the Terreros reports, which were commissioned by AABB.
AABB
StockItOut StockItOut 21 seconds ago
You're right.
XERI
Hestheman47 Hestheman47 2 minutes ago
Hey Stervc, hope all is well. I think you misunderstood.....I never had a position in MONI. What I was saying is that I have not been playing any OTC stocks and I haven't for years, BUT MONI is making me think about jumping back into the OTC market. It looks like it has alot going for it. I will be
MONI
RealDutch RealDutch 3 minutes ago
I keep telling him. This message board is none of his business. He shouldn't even be reading it.

Anyway, he said he expects the wire in the next 3 hours, from India. I'm not even sure if we should pay attention to anything he says anymore.
ITUP
Riley4 Riley4 5 minutes ago
Hey FeMike, got a great idea, so stay with me. I live in Eagleville tn and my current house value $500,000 more or less, this area has limited land so new house values upward $600,000 to 1mil plus. So if you buy around 2 million shares you will be covered when approval, then hits your share predicti
NWBO
Riley4 Riley4 5 minutes ago
Hey FeMike, got a great idea, so stay with me. I live in Eagleville tn and my current house value $500,000 more or less, this area has limited land so new house values upward $600,000 to 1mil plus. So if you buy around 2 million shares you will be covered when approval, then hits your share predicti
NWBO
BDEZ BDEZ 5 minutes ago
What's Demigender??????

https://x.com/MAGAVoice/status/1873845413276770384
researcher59 researcher59 5 minutes ago
My initial 4 picks, subject to revision by the Friday 4pm deadline -

HALO, NOA, SD, TOL
Preciouslife1 Preciouslife1 6 minutes ago
https://www.mlb.com/news/yankees-rumors-latest-trades-and-signings
nowwhat2 nowwhat2 7 minutes ago
What, THESE ones ?

https://investorshub.advfn.com/uimage/uploads/2024/12/30/hrsmbBTC_121212_26_45D_7AM_REAPER_DIAG_HORIZ_100K.jpg



4 1/2 days later - (107 hours)
https://investorshub.advfn.com/uimage/uploads/2024/12/30/ltzwzbtc_121212_30_45d_8p
XRPUSD
TheFinalCD TheFinalCD 7 minutes ago
tomorrow should be interesting
SIDU
TenKay TenKay 8 minutes ago
“Finally, the preferred B shares - after you remove Foote's shares…“

Why would you remove Foote’s shares? Is he returning them to the company?
HMBL
Moonboy1 Moonboy1 9 minutes ago
Never seen a stock rise the same day it announces offerings. Strange one here
WIMI
easymonee easymonee 10 minutes ago
Very interesting what Grok has to say about Real Game Used (RGU) photo match technology. RGU is the the private company associated with the CEO of MDCE. Article refers to the Jordan baseball shoes coming up for auction.

This AI driven system is a cutting edge approach in the memorabil
MDCE
karlacorn3 karlacorn3 11 minutes ago
If true, it's beyond silly. It's actually quite disturbing.
K
ITUP
Tahoe2468 Tahoe2468 11 minutes ago

Show me a perfect BULL FLAG without showing me a PERFECT BULL FLAG 😂😂😂
HOLO
Stock_Barber Stock_Barber 13 minutes ago
Pumpers have NO shame when their bags are full and their trading account is showing nothing but dust!



https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Fmedia.giphy.com%2Fmedia%2FgyYJYyCPezUWI%2Fgiphy.gif&f=1&nofb=1&ipt=976c7fd7e371ddc7553cc3505876564491306369
DBMM
Shawonsarker84 Shawonsarker84 14 minutes ago
Thank you NoMoDo! We are getting close soon I think. Have you seen SMX action today? I had a hard time focusing at work lol
SMX
pitcook pitcook 14 minutes ago
I did that Profit. I had them run it up the chain of command and said I would sign a waiver, and also I owned shares of the stock already at all three of these brokerage firms. Unequivocally the volume and share price is being held down until they get back on the bulletin board.
IVDN
GoodGuyBill GoodGuyBill 14 minutes ago
Doc answered you. You don't like the answer because it doesn't fit your narrative.

Your question: Doc

Please help us understand why couldn't they tell the shareholders what the reason for screening halt was when the trial was over and data locked . There could have been
NWBO
NY1972 NY1972 16 minutes ago
FT819 can act as a ligand sink and change DC/CD8, NLR ratios in 2nd lymphoid and inflammed tissues. Creating a new Bronx so to speak.

CXCR4 is critical for the organization of secondary lymphoid tissues, such as lymph nodes and spleen, where immune responses are initiated.
Dysr
FATE
Guido2 Guido2 17 minutes ago
Count me in.
FNMA
Hardazoak Hardazoak 17 minutes ago
Pictures from last weeks say other story. Stop with the blatant lies doe.
AABB

Your Recent History

LSE
OXB
Oxford Biomedica
MRTX
ARNXETH
Aeron
NYSE
VLRS
Volaris Aviation
TG
ILT
Illinois Tool Works
BOV
CGAS5R
COMGÁS PNA
BOV
CAMB3
Cambuci ON
DOWI
DJTBAST
DJ Basic Resources Titan...
FX
ZARJPY
ZAR vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads